- Home
- NRSN vs AMPG Comparison
NRSN vs AMPG Comparison
Compare NRSN & AMPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- AMPG
- Stock Information
- Founded
- NRSN 2017
- AMPG 2002
- Country
- NRSN Israel
- AMPG United States
- Employees
- NRSN N/A
- AMPG N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- AMPG Telecommunications Equipment
- Sector
- NRSN Health Care
- AMPG Telecommunications
- Exchange
- NRSN Nasdaq
- AMPG Nasdaq
- Market Cap
- NRSN 26.0M
- AMPG 29.7M
- IPO Year
- NRSN 2021
- AMPG N/A
- Fundamental
- Price
- NRSN $0.91
- AMPG $1.49
- Analyst Decision
- NRSN Hold
- AMPG Strong Buy
- Analyst Count
- NRSN 1
- AMPG 1
- Target Price
- NRSN N/A
- AMPG $5.00
- AVG Volume (30 Days)
- NRSN 172.3K
- AMPG 261.6K
- Earning Date
- NRSN 04-08-2025
- AMPG 04-08-2025
- Dividend Yield
- NRSN N/A
- AMPG N/A
- EPS Growth
- NRSN N/A
- AMPG N/A
- EPS
- NRSN N/A
- AMPG N/A
- Revenue
- NRSN N/A
- AMPG $11,667,163.00
- Revenue This Year
- NRSN N/A
- AMPG N/A
- Revenue Next Year
- NRSN N/A
- AMPG $58.88
- P/E Ratio
- NRSN N/A
- AMPG N/A
- Revenue Growth
- NRSN N/A
- AMPG N/A
- 52 Week Low
- NRSN $0.51
- AMPG $0.64
- 52 Week High
- NRSN $2.25
- AMPG $6.43
- Technical
- Relative Strength Index (RSI)
- NRSN 29.02
- AMPG 40.96
- Support Level
- NRSN $1.00
- AMPG $1.52
- Resistance Level
- NRSN $1.13
- AMPG $1.91
- Average True Range (ATR)
- NRSN 0.08
- AMPG 0.14
- MACD
- NRSN -0.02
- AMPG -0.00
- Stochastic Oscillator
- NRSN 8.23
- AMPG 25.49
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.